One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20%

Amgen said Monday its cholesterol buster, Repatha, reduced the risk of death by 20% in a study of more than 12,000 high-risk patients. The post One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20% appeared first on Investor's Business Daily.